NSE IPO - Apply Online, Check Issue Date, Price, Lot Size & Allotment Status

Apply for NSE IPO:

Skip to main content

Live Erasca, Inc. Common Stock Share Price Chart

O H L

Erasca, Inc. Common Stock Performance Overview

Days Range
$15.00Low
$15.31High

Markets Today

Previous Close$15.34
Open$15.31
Volume345,783
Day's Range$15.00 - $15.31
52W Range$1.65 - $24.28
Market Cap$5.37 B

Historical Performance

1M Returns-15.25
3M Returns+12.22
6M Returns+13.63
1Y Returns+720.32
5Y Returns-21.01
10Y ReturnsNA

Erasca, Inc. Common Stock Fundamentals

Market Cap$5.37 B
Dividend yield0.00
PE Ratio0.00
PEG RatioN/A
Revenue$0.00
ROE TTM-0.33
EPS TTM$-0.95
Quarterly Earnings Growth YOYN/A
PB Ratio13.27
EBITDA$-137.80 M
Profit MarginN/A
Market Cap$5.37 B
Dividend yield0.00
PE Ratio0.00
PEG RatioN/A
Revenue$0.00
ROE TTM-0.33
EPS TTM$-0.95
Quarterly Earnings Growth YOYN/A
PB Ratio13.27
EBITDA$-137.80 M
Profit MarginN/A

Erasca, Inc. Common Stock Profit & Loss

Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Total Revenue +$0$0$0$0$0$0
Gross Profit +$0$0$0$0$0$0
Operating Income -$35.63 M-$38.13 M-$34.55 M-$32.60 M-$187.91 M-$47.62 M
EBITDA -$34.81 M-$37.34 M-$33.79 M-$31.86 M-$187.19 M-$46.90 M
Interest Expense $4.74 M$0$0$0$4.45 M$0
Depreciation $822.00 K$787.00 K$755.00 K$743.00 K$723.00 K$716.00 K
Income Before Tax -$30.97 M-$33.88 M-$30.61 M-$29.09 M-$183.44 M-$44.08 M
Income Tax Expense $0$0$0$0$0$0
Net Income +-$30.97 M-$33.88 M-$30.61 M-$29.09 M-$183.44 M-$44.08 M
Net Profit Margin ------

Erasca, Inc. Common Stock Financials Balance Sheet In USD

Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Share Capital $28.00 K$28.00 K$28.00 K$28.00 K$31.00 K$31.00 K
Reserve & Surplus -$798.00 M-$832.09 M-$862.47 M-$891.58 M-$1.08 B-$1.12 B
Non-Current Liabilities $46.27 M$44.98 M$43.80 M$42.47 M$41.04 M$39.61 M
Current Liabilities $25.47 M$28.15 M$28.71 M$28.51 M$26.66 M$33.57 M
Total Liabilities $71.74 M$73.13 M$72.52 M$70.98 M$67.71 M$73.19 M
Fixed Assets $15.59 M$14.82 M$14.04 M$13.30 M$12.61 M$11.92 M
Current Assets $314.62 M$310.66 M$299.93 M$286.24 M$253.78 M$278.44 M
Total Assets $471.24 M$445.39 M$420.40 M$396.15 M$461.23 M$435.05 M

Erasca, Inc. Common Stock Cash Flow

Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Net Income -$30.97 M-$33.88 M-$30.61 M-$29.09 M-$183.44 M-$44.08 M
Operating Cash Flow -$31.55 M-$20.53 M-$21.66 M-$21.71 M-$27.38 M-$27.27 M
Investing Cash Flow $34.27 M$15.74 M$25.70 M$24.71 M-$243.83 M$19.49 M
Financing Cash Flow $33.00 K$447.00 K$41.00 K$575.00 K$244.66 M$3.06 M
Change in Cash $2.74 M-$4.34 M$4.09 M$3.58 M-$26.55 M-$4.71 M

Erasca, Inc. Common Stock Peer Comparison

CompanyMarket Cap5 Years Return %PE RatioProfit Margin %Dividend Yield %
RVMD
$41.99B530.61%0.00NA0.00%

Erasca, Inc. Common Stock Return Calculator

The Erasca, Inc. Common Stock stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Returns Estimator

Based on past performance of this fund

ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$7,729
Invested Amount$10,000
Est. Returns$-2,271
Invest in USA Stock Today

About Erasca, Inc. Common Stock

Erasca Inc is a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. Its focused RAS/MAPK pathway pipeline comprises modality-agnostic programs aligned with three therapeutic strategies of: targeting key upstream and downstream signaling nodes in the RAS/MAPK pathway; targeting RAS directly; and targeting escape routes that emerge in response to treatment. Its pipeline includes two clinical-stage programs (ERAS-0015, a pan-RAS molecular glue; and ERAS-4001, a pan-KRAS inhibitor), and ERAS-12, a discovery-stage program.

FAQs

Erasca, Inc. Common Stock (ERAS) share price as of September 18, 2026 is $15.01. If you are investing from India, you can always check the valuation in the INR before investing.
Yes, Indian Investors can invest in the Erasca, Inc. Common Stock (ERAS) Share by opening an international trading account with Angel One.
Purchasing Erasca, Inc. Common Stock (ERAS) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying Erasca, Inc. Common Stock (ERAS) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Yes, you can purchase fractional shares of Erasca, Inc. Common Stock (ERAS) or any other US company shares in Angel One for any dollar amount.
The market capitalization of Erasca, Inc. Common Stock on September 18, 2026, is $5.37 B.
Erasca, Inc. Common Stock operates in the Healthcare sector, specifically in the Healthcare industry.
In order to invest in Erasca, Inc. Common Stock (ERAS) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.

Diversify Your Portfolio with US Stocks

Invest in Wall Street Giants from India

+91
Top US Stocks

VIEW ALL

Open Free Demat Account!

Join our 3.8 Cr+ happy customers
+91